Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trialClaus Rödel, Torsten Liersch, Michael Ghadimi et al.|The Lancet Oncology|2015Cited by 723
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12Emmanouil Fokas, Michael Allgäuer, Bülent Polat et al.|Journal of Clinical Oncology|2019Cited by 536
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerEmmanouil Fokas, Katica Krajinovic, Anke Schlenska‐Lange et al.|JAMA Oncology|2021Cited by 349
International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancerEmmanouil Fokas, Claus Rödel, Ane Appelt et al.|Nature Reviews Clinical Oncology|2021Cited by 242